All News

PSORIASIS.LH_.jpg

Psoriasis to Psoriatic Arthritis: Interim Results of the PRESTO Study

d Sheila Reyes, MD

Early diagnosis of arthritis improves outcomes and quality of life in patients with psoriasis. A longitudinal cohort study shows that the development of PsA within clinically meaningful time frames can be predicted with reasonable accuracy for psoriasis patients.

Read Article
virtual online learning home office zoom

Building an ACR Annual Meeting for the Whole World

d David Liew, FRACP

For many rheumatologists around the world, coming to America was a pilgrimage of sorts. A long journey and an expensive exercise but a worthy one – a fundamentally human exchange of ideas, where the person next to you could be from Arkansas, Alberta, or Amsterdam, but equally from Argentina, Algeria, Azerbaijan, or even Australia. So how (dare I say, on earth) do we translate that to our electronic screens?

Read Article
journal book learning study meeting notes

Excited About ACR Convergence 2020

d Antoni Chan, MD, PhD

I always think of why I attend the ACR: to gain new information and knowledge and bring it back to my clinic for my patients. Here's what I'm looking forward to this year.

Read Article
covid19.logo_.jpg

Six Things Rheumatologists Need to Know About COVID-19

d Rachel Tate, DO

From flu shots and face masks to vaccines and searching for the immunological endotype, here are six things rheumatologists need to know about COVID-19.

Read Article
ACRmtg.jpg (keep)

Industry Abstract Previews - ACR2020

d Jack Cush, MD

Each pharmaceutical company has spent months and years preparing to present and highlight their featured clinical trials and abstracts at ACR 2020.  This is our selection of their best studies for you to review and evaluate as part of your to-do list.

Read Article
#ACR20 @RheumNow https://t.co/iLJpK6Ic00

Links:

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

The Great Debate is a “must see” session! #ACR20 @RheumNow https://t.co/XvFD83njUo

Links:

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

Oxylipins, biological lipids found in inflammatory processes, were low in PsO/PsA pts w/ ^ skin scores, high in enthesitis, no change in joint dz activity in PsA pts. More trials needed to further understand this relationship. #ABS0318 @RheumNow #ACR20 https://t.co/4keGOy7BIA https://t.co/7CeB3kh4xi

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Psoriasis to psoriatic arthritis: check out my news article on the PRESTO study 👇 @RheumNow #ACR20 Abstr#0310 https://t.co/nDV1NFqh30

Links:

sheila RHEUMarampa ( View Tweet)

Abs#0012 at #ACR20 shows #rheumatology patients in the US had significant changes to healthcare and access to meds during #COVID19. https://t.co/2x7j47WiZL For patients & clinicians: what do you consider to be the most important impact on rheumatology due to COVID-19? @RheumNow

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

ACR Convergence 2020 attendees – you won’t want to miss the virtual #ACR20 Tweet Up on Friday, Nov. 6, from 6:00 - 7:00 PM ET, in the COVID-19 Community Hub! https://t.co/kf32RCEem2
American College of Rheumatology ACRheum ( View Tweet)
Huge congrats @kmdsilvaMD on your @RheumResearch Scientist Development Award- "Respiratory Complications of #COVID19 in Rheumatic Diseases." Be sure to also join Kristin tomorrow as she presents at the #ACR20 plenary! @MGH_ClinEpi https://t.co/LamvuWTMIW
MGH Rheumatology MGHrheumatology ( View Tweet)
https://t.co/yw7CGHJ6XS
Jeff Sparks jeffsparks ( View Tweet)
Delighted to be reporting for @RheumNow at #ACR20! Here, I review the last year in #infection in #rheumaticdiseases (it’s been a busy one!) and highlight just a few of the abstracts on infections (incl #COVID19), #vaccination and #immunogenicity. Enjoy! https://t.co/x1pzyOICAF

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

Association of Hydroxychloroquine Use with Development of Non-Alcoholic Fatty Liver Disease in Rheumatoid Arthritis https://t.co/3PrWlIGnB8 #RA #HCO #NASH - HCO decreases fatty liver

Links:

Peter Nash drpnash ( View Tweet)

Lymphomas Complicating Rheumatoid Arthritis: Results of a French Multi-Centre Case-Control Study https://t.co/NDk0LH5Kk6 #RA #lymphoma risk driven by increased disease activity

Links:

Peter Nash drpnash ( View Tweet)

Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 8.4 Years: An Updated Integrated Safety Analysis https://t.co/i456zSn6Ba #RA #Baricitinib #safety 13000 pt/yrs 8.4 yrs F/U no new safety signals VTE 0.5/100 pt yrs

Links:

Peter Nash drpnash ( View Tweet)

COVID-19 use of dexamethasone- why does it work? When to use it ?Is it hyperferrintemic sepsis? Vs early MAS vs? More data needed but this why rheumatologists are needed!!! @RheumNow #ACR20 thank you dr. Rubin! https://t.co/MvQJGqsqu2
alexa meara lexmeara ( View Tweet)
What is your top concern about the SARS-Co-V2 vaccine for rheum patients? @RheumNow #ACR20

k dao KDAO2011 ( View Tweet)

@JYazdanyMD @UWRheum @r_burmester Black, et al - cont'd 277 atypical femur fx events Risk increased w longer duration of bisphosphonate use Risk decreased after bisphosphonate discontinuation Asians had a higher risk than Whites. #ACR20 #ACRambassador

Rheum Cat rheum_cat ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×